Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China.

More than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

LILLE, France , Oct. 29, 2024 /PRNewswire/ -- Vaxinano, a pioneering biotech company specializing in the development of prophylactic and therapeutic nasal vaccines, has successfully raised €6 ...

AuraVax collaborates with Codagenix Inc. to demonstrate NanoSTING-002 with intranasal live-attenuated vaccines to improve immune protection and provide path to a universal vaccine. AuraVax will ...